Neil Chatterji
Stock Analyst at B. Riley Securities
(1.10)
# 3,669
Out of 4,893 analysts
19
Total ratings
23.53%
Success rate
-0.36%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $11.96 | +134.11% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $13.46 | -3.42% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $45.98 | +8.74% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.41 | +431.91% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $13.96 | +28.94% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $3.73 | +20.64% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $0.78 | +346.43% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.24 | +145.54% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $1.87 | +408.02% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $11.96
Upside: +134.11%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $13.46
Upside: -3.42%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $45.98
Upside: +8.74%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.41
Upside: +431.91%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $13.96
Upside: +28.94%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.73
Upside: +20.64%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $0.78
Upside: +346.43%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.24
Upside: +145.54%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $1.87
Upside: +408.02%